Merck stock (NYSE: MRK) has gained over 65% in value since early January 2021 – jumping from levels of $70 then to around $115 now – vs. an increase of about 50% for the S&P 500 over this period. This ...
Merck & Co., Inc. (NYSE:MRK) has explored a potential acquisition of Swiss biotech firm MoonLake Immunotherapeutics in a deal valued at over $3 billion, aiming to strengthen its drug pipeline. The ...
Merck (NYSE:MRK) shares inched lower in the pre-market trading Monday after Wells Fargo downgraded the pharma giant from Overweight to Equal Weight, citing concerns about its valuation. The analyst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback